Publicaciones en colaboración con investigadores/as de Universidad de Valladolid (25)

2023

  1. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  2. Endothelial nitric oxide synthase rs1799983 gene polymorphism is associated with the risk of developing intracranial aneurysm

    Acta Neurochirurgica, Vol. 165, Núm. 5, pp. 1261-1267

  3. Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake

    Antioxidants, Vol. 12, Núm. 9

2022

  1. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  2. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

  3. Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration

    Frontiers in Neuroanatomy, Vol. 16

  4. Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death

    Investigative ophthalmology & visual science, Vol. 63, Núm. 4, pp. 27

2021

  1. Analysis of Lymphotoxin Alpha Expression in Human Retina and Generation of Expression Vectors to Functional Characterization of Polymorphisms in the Tumor Necrosis Factor Locus

    Methods in Molecular Biology (Humana Press Inc.), pp. 243-250

  2. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  3. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  4. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  5. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

2020

  1. Clinical perspective and translational oncology of liquid biopsy

    Diagnostics, Vol. 10, Núm. 7

  2. Identification of a truncated β1-chimaerin variant that inactivates nuclear Rac1

    Journal of Biological Chemistry, Vol. 295, Núm. 5, pp. 1300-1314

  3. Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer’s biomarkers

    Diagnostics, Vol. 10, Núm. 4

2019

  1. Meta-analysis of the rs243865 MMP-2 polymorphism and age-related macular degeneration risk

    PLoS ONE, Vol. 14, Núm. 3

2016

  1. Rho GTPases and Their Regulators in Addiction: A Focus on the Association of a β2-Chimaerin Polymorphism with Smoking

    Neuropathology of Drug Addictions and Substance Misuse Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids (Elsevier), pp. 125-132

2014

  1. Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia

    Annals of General Psychiatry, Vol. 13, Núm. 1

2013

  1. Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles

    Human Mutation, Vol. 34, Núm. 12, pp. 1615-1618

  2. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer

    Colorectal Disease, Vol. 15, Núm. 3